HIV protease inhibitors useful for the treatment of AIDS
US5413999A · kind A · utility
118Cited by
5References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 1993 |
| Grant date | May 9, 1995 |
| Priority date | — |
| Expiry date | May 7, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula ##STR1## where R.sup.1 and R.sup.2 are independently hydrogen or optionally-substituted C.sub.1-4 alkyl or aryl, or R.sup.1 and R.sup.2 are joined together to form a monocyclic or bicyclic ring system, are HIV protease inhibitors. These compounds are useful in the treatment of infection by HIV and in the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of treating infection by HIV are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.